BRD2 and gastric cancer: Given the large number of eccDNAs detected in GCT samples, the higher ratio of “eccDNAs within 250 ~ 1000 bp” indicated that GCT contained much more and longer eccDNAs than that of NAT, suggesting the gastric cancer cells were prone to produce relatively longer eccDNAs which were capable of carrying longer functional genomic segments.